Management of Tongue Leukoplakia

Initial Risk Stratification

• Non-homogeneous leukoplakia carries a significantly higher malignant transformation risk than homogeneous white plaques and requires aggressive management 3

Primary Treatment: ALA-PDT Protocol

• The American College of Physicians recommends verifying patient eligibility for ALA-PDT by excluding absolute contraindications such as porphyria history, coagulopathy, pregnancy, uncontrolled severe systemic disorders, or allergies to light/porphyrin/anesthesia 1
• Baseline vital signs should be checked, including systolic BP ≤140 mmHg, diastolic BP ≤90 mmHg, and heart rate ≤100 bpm, as recommended by the International Journal of Oral Science 4
• Obtain baseline blood counts, glucose, coagulation studies, and liver/kidney function, as recommended by the International Journal of Oral Science 4
• Patient should gargle with 0.1% chlorhexidine solution for 1 minute, as recommended by the International Journal of Oral Science 4
• Photosensitizer preparation involves dissolving ALA in sterile water to create a 20% aqueous solution immediately before use, as recommended by the American College of Physicians 1, 2
• Application of photosensitizer-soaked cotton swab to the lesion, extending 3-5 mm beyond lesion margins, and covering with starch film and food-grade cling film, is recommended by the International Journal of Oral Science 4
• Incubation time of 2-3 hours is recommended by the International Journal of Oral Science 4
• Local anesthesia with 2% lidocaine or 4% primacaine before laser exposure is recommended by the American College of Physicians 1
• Laser settings should be a semiconductor laser at 630 nm ± 5 nm, power 100 mW/cm², as recommended by the American College of Physicians 1, 2
• Irradiation protocol involves 3-minute exposure sessions alternating with 3-minute rest periods until a total dose reaches 100 J/cm², as recommended by the American College of Physicians 1
• Treatment frequency should be every 2-3 weeks based on healing response, as recommended by the American College of Physicians 1

Expected Outcomes

• Response rates range from 50-100%, with complete response in 16.49-88.89% of cases, as reported by the American College of Physicians 1
• Recurrence rates vary from 0-41% over 1-30 months follow-up, as reported by the American College of Physicians 1
• Assess treatment response at 4 weeks after the final treatment session, as recommended by the American College of Physicians 1

Post-Treatment Management

• Prevent all light exposure to the treated area for a minimum of 48 hours, as recommended by the American College of Physicians 1, 2
• Prescribe 0.01% dexamethasone paste topically to reduce inflammation, as recommended by the American College of Physicians 1
• Continue 0.1% chlorhexidine gargling solution, as recommended by the American College of Physicians 1
• Instruct patient to avoid irritating foods and beverages, as recommended by the American College of Physicians 1

Alternative Treatment Options

• CO2 laser ablation is an effective alternative treatment option, but may cause more scarring than PDT, as reported by the American College of Physicians 2
• Electrocauterization is associated with a higher risk of thermal damage, as reported by the American College of Physicians 2
• Cryosurgery is associated with postoperative pain, edema, and scarring, as reported by the American College of Physicians 2

Critical Pitfalls to Avoid

• Failing to enforce strict light avoidance for 48+ hours post-PDT is a common error that compromises outcomes, as reported by the American College of Physicians 1
• Underestimating non-homogeneous lesions, which require aggressive treatment regardless of initial biopsy showing benign hyperkeratosis, as reported by the American College of Physicians 3

Long-Term Surveillance

• Tobacco cessation is essential, as 75% of oral cancers are attributable to tobacco and alcohol use, as reported by the Annals of Internal Medicine 5